The future of liquid biopsy

The analysis of tumours using biomarkers in blood is beginning to transform cancer diagnosis, says Catherine Alix-Panabieres. The challenge now is to make liquid biopsy a standard clinical tool. The analysis of tumours using biomarkers in blood is beginning to transform cancer diagnosis, says Catherine Alix-Panabieres. The challenge now is to make liquid biopsy a standard clinical tool.